| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.IT.2019.02.003 |
| P698 | PubMed publication ID | 30890304 |
| P2093 | author name string | Judith A Varner | |
| Paulina Pathria | |||
| Tiani L Louis | |||
| P2860 | cites work | L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity | Q37359052 |
| P433 | issue | 4 | |
| P304 | page(s) | 310-327 | |
| P577 | publication date | 2019-03-17 | |
| P1433 | published in | Trends in Immunology | Q15265730 |
| P1476 | title | Targeting Tumor-Associated Macrophages in Cancer | |
| P478 | volume | 40 |
| Q96111780 | A melt-electrowritten filter for capture and culture of circulating colon cancer cells |
| Q92645982 | Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer Progression |
| Q103825537 | Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer |
| Q97595573 | Basement membrane damage by ROS- and JNK-mediated Mmp2 activation drives macrophage recruitment to overgrown tissue |
| Q89906004 | CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis |
| Q92977405 | Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities |
| Q95643287 | Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration |
| Q103826247 | Emerging immunotherapies for metastasis |
| Q92156072 | Extracellular Hsp70 Reduces the Pro-Tumor Capacity of Monocytes/Macrophages Co-Cultivated with Cancer Cells |
| Q104459068 | Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173/STING-dependent DNA sensor pathway |
| Q92027543 | From Vaccine Vector to Oncomodulation: Understanding the Complex Interplay between CMV and Cancer |
| Q91697983 | Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer |
| Q92353409 | Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro |
| Q95327672 | Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment |
| Q91728737 | Harnessing tumor-associated macrophages as aids for cancer immunotherapy |
| Q91805595 | How cancers usurp macrophages to keep growing |
| Q92186275 | Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients |
| Q91904998 | Immunotherapies for pediatric cancer: current landscape and future perspectives |
| Q91742583 | Immunotherapy in anaplastic thyroid cancer |
| Q91743168 | Integrins: Moonlighting Proteins in Invadosome Formation |
| Q90690112 | Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype |
| Q90043581 | Melanoma Metabolism: Cell Survival and Resistance to Therapy |
| Q89968494 | Modeling chemical effects on breast cancer: the importance of the microenvironment in vitro |
| Q99710834 | Multi-omics analysis identifies FoxO1 as a regulator of macrophage function through metabolic reprogramming |
| Q92129617 | Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment |
| Q98612770 | Past, Present, and Future of Anticancer Nanomedicine |
| Q92760428 | Peptide-based targeting of immunosuppressive cells in cancer |
| Q96304655 | Positive Allosteric Modulation of CD11b as a Novel Therapeutic Strategy Against Lung Cancer |
| Q99709271 | Positron Emission Tomography for Response Evaluation in Microenvironment-Targeted Anti-Cancer Therapy |
| Q98159062 | Prognostic value of immune cell infiltration in bladder cancer: A gene expression-based study |
| Q90281713 | Recipient Hepatic Tumor-Associated Immunologic Infiltrates Predict Outcomes After Liver Transplantation for Hepatocellular Carcinoma |
| Q98735563 | Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment |
| Q99709001 | SFMBT2-Mediated Infiltration of Preadipocytes and TAMs in Prostate Cancer |
| Q91981643 | Strategies to Interfere with Tumor Metabolism through the Interplay of Innate and Adaptive Immunity |
| Q90481727 | Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel |
| Q99617225 | Targeting tumor-associated macrophages in the tumor microenvironment |
| Q99605605 | The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance |
| Q92239433 | The Remarkable Plasticity of Macrophages: A Chance to Fight Cancer |
| Q91696491 | Toward Normalization of the Tumor Microenvironment for Cancer Therapy |
| Q93051833 | Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities |
| Q90131626 | Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma |
| Q90473178 | Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response |
| Q92936015 | Tumor-infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer |
| Q92556918 | Tuning the Tumor Myeloid Microenvironment to Fight Cancer |
| Q92538413 | Understanding and Modulating Immunity With Cell Reprogramming |
| Q93012980 | VGLL3 is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in stomach adenocarcinoma |
Search more.